In vivo Bioequivalence study of Aspirin tablet

Not Applicable

Recruiting

• Conditions: In the present study, the products will be administered to healthy volunteers..

• Registration Number: IRCT20220211053992N6
• Lead Sponsor: Tabriz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: Male
• Target Recruitment: 24

Inclusion Criteria

General Health (in terms of Liver, Heart and Kidney diseases)
Age between 18 to 60 years

Exclusion Criteria

Smoking,
History of cardiovascular, liver, and kidney disease
Pregnancy
Alcohol and drug addiction
History of drug allergy

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Plasma concentration of drug. Timepoint: 0.5-24 hours in predetermined time intervals after drug administration. Method of measurement: HPLC (High performance liquid chromatography).